Stereotaxis (STXS) director granted 46,948 RSUs in equity award

Rhea-AI Filing Summary

Stereotaxis, Inc. reported an equity award to one of its directors. On 01/02/2026, the director received a grant of 46,948 restricted share units, each representing a right to receive one share of Stereotaxis common stock. The transaction price is listed as $0, reflecting that this was an equity compensation grant rather than a market purchase.

After this award, the director beneficially owns 392,058 shares of common stock. The restricted share units vest on the earliest of the fifth anniversary of the award date, the date the director’s board service ends, or a defined Change of Control event. This filing is a routine disclosure of director compensation and ownership under insider reporting rules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

C/O STEREOTAXIS, INC.

710 NORTH TUCKER BLVD., SUITE 110

(Street)

ST. LOUIS MO 63101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		46,948(1)	A	$0	392,058	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

	/s/ Kimberly R. Peery, Attorney-in-Fact for Myriam Curet	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stereotaxis (STXS) disclose in this Form 4?

The company disclosed that a director received a grant of 46,948 restricted share units of Stereotaxis common stock on 01/02/2026 as equity compensation.

What are the vesting terms of the new restricted share units at Stereotaxis (STXS)?

The 46,948 restricted share units vest on the earliest of five years from the award date, the date the director’s board service ends, or a defined Change of Control of the company.

How many Stereotaxis (STXS) shares does the director own after this transaction?

Following the reported grant, the director beneficially owns 392,058 shares of Stereotaxis common stock, as shown in the Form 4.

Was cash paid for the Stereotaxis (STXS) restricted share units granted to the director?

No cash was paid; the transaction price is listed as $0, indicating it is a compensatory equity award rather than a market purchase.

What does each restricted share unit represent in the Stereotaxis (STXS) grant?

Each restricted share unit represents a right to receive one share of Stereotaxis common stock, subject to the vesting conditions described in the award.

What is the relationship of the reporting person to Stereotaxis (STXS)?

The reporting person is identified as a Director of Stereotaxis, Inc., and the Form 4 is filed for one reporting person.